Clinical Coagulation, Malmö
351 – 360 of 659
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
- Contribution to journal › Article
-
Mark
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.
- Contribution to journal › Article
- 2012
-
Mark
Arterial Thrombosis in Factor V Leiden or Activated Protein C Resistance. Clinical and Experimental Studies.
- Thesis › Doctoral thesis (compilation)
-
Mark
Mortality and Inherited Thrombophilia: results from the European Prospective Cohort on Thrombophilia (EPCOT).
- Contribution to journal › Article
-
Mark
Differences between developed and developing countries in paediatric care in haemophilia
- Contribution to journal › Article
-
Mark
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry
- Contribution to journal › Article
-
Mark
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
- Contribution to journal › Scientific review
-
Mark
Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
- Contribution to journal › Letter
-
Mark
A prospective registry of European haemophilia B patients receiving nonacog alfa, recombinant human factor IX, for usual use.
- Contribution to journal › Article
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
- Contribution to journal › Article
